|
DPY30 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.794140E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.918500E-02 |
| Normal-vs-Stage2 |
8.996300E-02 |
| Normal-vs-Stage3 |
2.308600E-01 |
| Normal-vs-Stage4 |
6.457800E-02 |
| Stage1-vs-Stage2 |
5.580000E-01 |
| Stage1-vs-Stage3 |
5.421200E-01 |
| Stage1-vs-Stage4 |
9.735800E-01 |
| Stage2-vs-Stage3 |
3.377800E-01 |
| Stage2-vs-Stage4 |
5.934600E-01 |
| Stage3-vs-Stage4 |
5.844600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.773900E-02 |
| Normal-vs-AfricanAmerican |
5.946500E-02 |
| Normal-vs-Asian |
1.907160E-01 |
| Caucasian-vs-AfricanAmerican |
3.887800E-01 |
| Caucasian-vs-Asian |
7.286000E-01 |
| AfricanAmerican-vs-Asian |
9.997800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.536100E-02 |
| Normal-vs-Female |
2.006200E-02 |
| Male-vs-Female |
5.098000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.164400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.430200E-02 |
| Normal-vs-Age(61-80Yrs) |
2.461800E-02 |
| Normal-vs-Age(81-100Yrs) |
4.479000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.312600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.585800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.599800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.617800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.081600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.308200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.704240E-02 |
| Normal-vs-Grade 2 |
1.768130E-02 |
| Normal-vs-Grade 3 |
2.620400E-02 |
| Normal-vs-Grade 4 |
7.771400E-01 |
| Grade 1-vs-Grade 2 |
4.718600E-01 |
| Grade 1-vs-Grade 3 |
3.229000E-01 |
| Grade 1-vs-Grade 4 |
1.075820E-01 |
| Grade 2-vs-Grade 3 |
7.538800E-01 |
| Grade 2-vs-Grade 4 |
1.323170E-01 |
| Grade 3-vs-Grade 4 |
1.382160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.07150000000045E-05 |
| Normal-vs-ccB subtype |
4.140800E-01 |
| ccA subtype-vs-ccB subtype |
4.24979999968933E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.340500E-02 |
| Normal-vs-N1 |
7.555000E-01 |
| N0-vs-N1 |
3.503600E-01 |
|
|
